1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)- ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt

Details for Australian Patent Application No. 2005293196 (hide)

Owner Actelion Pharmaceuticals Ltd

Inventors Buchmann, Stephan; Woinet, Bertrand; Redey, Stephane; Bonard, Jean Michel

Agent A J Park

Pub. Number AU-B-2005293196

PCT Pub. Number WO2006/040728

Priority PCT/ EP2004/011410 12.10.04 EP

Filing date 11 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 22 March 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/040728 Priority application(s): WO2006/040728

22 March 2012 Application Accepted

  Published as AU-B-2005293196

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293216-An instrument access device

2005293163-System of automatic control of maneuver of motor crafts, related method, and craft provided with the system